Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Statistics

Total Valuation

RYTM has a market cap or net worth of $3.75 billion. The enterprise value is $3.55 billion.

Market Cap	3.75B
Enterprise Value	3.55B

Important Dates

The last earnings date was Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RYTM has 63.62 million shares outstanding. The number of shares has increased by 5.45% in one year.

Current Share Class	63.62M
Shares Outstanding	63.62M
Shares Change (YoY)	+5.45%
Shares Change (QoQ)	+2.37%
Owned by Insiders (%)	0.65%
Owned by Institutions (%)	78.25%
Float	47.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.59
Forward PS	18.45
PB Ratio	197.60
P/TBV Ratio	288.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	25.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.70.

Current Ratio	3.30
Quick Ratio	2.97
Debt / Equity	0.70
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.47

Financial Efficiency

Return on equity (ROE) is -150.20% and return on invested capital (ROIC) is -74.16%.

Return on Equity (ROE)	-150.20%
Return on Assets (ROA)	-51.33%
Return on Invested Capital (ROIC)	-74.16%
Return on Capital Employed (ROCE)	-96.42%
Revenue Per Employee	$483,615
Profits Per Employee	-$614,912
Employee Count	283
Asset Turnover	0.42
Inventory Turnover	1.02

Taxes

In the past 12 months, RYTM has paid $126,000 in taxes.

Income Tax	126,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.65% in the last 52 weeks. The beta is 2.37, so RYTM's price volatility has been higher than the market average.

Beta (5Y)	2.37
52-Week Price Change	+50.65%
50-Day Moving Average	56.65
200-Day Moving Average	54.30
Relative Strength Index (RSI)	46.88
Average Volume (20 Days)	686,159

Short Selling Information

The latest short interest is 4.85 million, so 7.63% of the outstanding shares have been sold short.

Short Interest	4.85M
Short Previous Month	5.11M
Short % of Shares Out	7.63%
Short % of Float	10.25%
Short Ratio (days to cover)	5.10

Income Statement

In the last 12 months, RYTM had revenue of $136.86 million and -$174.02 million in losses. Loss per share was -$2.82.

Revenue	136.86M
Gross Profit	122.65M
Operating Income	-265.02M
Pretax Income	-258.09M
Net Income	-174.02M
EBITDA	-263.48M
EBIT	-265.02M
Loss Per Share	-$2.82

Balance Sheet

The company has $314.49 million in cash and $113.59 million in debt, giving a net cash position of $200.90 million or $3.16 per share.

Cash & Cash Equivalents	314.49M
Total Debt	113.59M
Net Cash	200.90M
Net Cash Per Share	$3.16
Equity (Book Value)	163.09M
Book Value Per Share	0.30
Working Capital	257.47M

Cash Flow

Operating Cash Flow	-113.49M
Capital Expenditures	n/a
Free Cash Flow	-113.49M
FCF Per Share	-$1.78

Margins

Gross margin is 89.62%, with operating and profit margins of -193.64% and -123.28%.

Gross Margin	89.62%
Operating Margin	-193.64%
Pretax Margin	-123.19%
Profit Margin	-123.28%
EBITDA Margin	-192.51%
EBIT Margin	-193.64%
FCF Margin	n/a

Dividends & Yields

RYTM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.45%
Shareholder Yield	-5.45%
Earnings Yield	-4.64%
FCF Yield	-3.03%

Analyst Forecast

The average price target for RYTM is $75.42, which is 27.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$75.42
Price Target Difference	27.91%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	62.36%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RYTM has an Altman Z-Score of 2.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.7
Piotroski F-Score	3